Skip to main content

Glenmark zooms 9% on DCGI nod to conduct clinical trials for Covid-19 drug

Glenmark is the first pharma company in India to be given an approval by the regulator to start the trial on COVID-19 patients

from Home Page https://ift.tt/2WeRiBd

Comments

Popular posts from this blog